Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2319 publications
Cost-effectiveness analysis of larotrectinib vs standard of care for treatment of metastatic NTRK fusion colorectal cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 12, 2025
A systematic review of cost-effectiveness studies of later-line treatments for refractory metastatic colorectal cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 11, 2025
Optimized Dosing of Regorafenib in Patients With Metastatic Colorectal Cancer: A Practical Guide for Oncologists, Advanced Practice Providers, and Pharmacists.
Journal: Journal of the advanced practitioner in oncology
Published: December 05, 2025
Angiogenesis Inhibitors and Arterial Dissection or Aneurysm in Patients With Metastatic Colorectal Cancer.
Journal: JAMA network open
Published: December 04, 2025
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastoma.
Journal: bioRxiv : the preprint server for biology
Published: December 03, 2025
Regorafenib in adult patients with recurrent glioblastoma: a single-arm meta-analysis.
Journal: Journal of chemotherapy (Florence, Italy)
Published: November 20, 2025
Regorafenib promotes ferroptosis in acute myeloid leukemia by upregulating NOX4.
Journal: Biochemical and biophysical research communications
Published: November 02, 2025
Precision design of ferritin nanocages: tumor-targeted delivery, multi-mechanism synergistic therapy and clinical translational challenges.
Journal: Drug development and industrial pharmacy
Published: October 29, 2025
Hyaluronic acid capped cubosomes co-loaded with antitumor agents towards the treatment of colorectal cancer.
Journal: Scientific reports
Published: October 09, 2025
Vascular endothelial cells and angiogenesis.
Journal: Pharmacological research
Published: October 04, 2025
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study.
Journal: Cancers
Published: October 02, 2025
Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2‑associated sensitivity in ACHN models.
Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: September 20, 2025
Last Updated: 01/07/2026